OstroVit MCT Oil Powder 200 g

The dietary supplement OstroVit MCT Oil is a high-quality product that provides a source of valuable MCT oil. This oil contains many active substances, including caproic, caprylic, capric, lauric, myristic, and palmitic acids. OstroVit's product has a simple composition, free from additives, preservatives, flavor enhancers, and unnecessary colorants. It is presented in powder form.

The MCT oil is a blend of medium-chain fatty acids of the highest quality. It differs from saturated fats by its much faster digestion process. They are absorbed in the liver and not in the intestine like other fats. MCTs consist of 6 to 10 carbon atoms. They are mainly found in the coconut palm.

The caprylic acid is a substance that has the ability to acylate ghrelin, the hunger hormone. Acylation of ghrelin results in the inhibition of its orexigenic effect, which translates into a reduction of cravings. [1]

MCTs also contribute to reducing LDL ("bad" cholesterol) and increasing HDL ("good" cholesterol). They have properties similar to those of olive oil[2]. [2]

Caprylic acid helps restore cognitive functions in people who have experienced cognitive decline. It follows that MCT supplementation can be beneficial for cognitive processes. [3]

In summary, the OstroVit MCT Oil supplement is a high-quality product that provides valuable MCT oil. This substance is a blend of medium-chain fatty acids that has many beneficial health properties. The formula has a simple and pure composition and a convenient liquid form for use.

1 Lemarié F, Beauchamp E, Legrand P, Rioux V. Reexamination of the metabolism and physiological functions of caprylic acid (C8:0) with a particular focus on ghrelin acetylation. Biochemistry. 2016 Jan;120:40-8. doi: 10.1016/j.biochi.2015.08.002. Epub 2015 Aug 4. PMID: 26253695.

2 St-Onge MP, Bosarge A, Goree LL, Darnell B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52. doi: 10.1080/07315724.2008.10719737. PMID: 18845704; PMCID: PMC2874191.

3 Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31. PMID: 19664276; PMCID: PMC2731764.